Clinical trials
Neoplasm Metastasis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
505 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 9 |
| 2006 | 12 |
| 2007 | 19 |
| 2008 | 11 |
| 2009 | 17 |
| 2010 | 18 |
| 2011 | 21 |
| 2012 | 25 |
| 2013 | 27 |
| 2014 | 25 |
| 2015 | 21 |
| 2016 | 24 |
| 2017 | 18 |
| 2018 | 20 |
| 2019 | 17 |
| 2020 | 24 |
| 2021 | 40 |
| 2022 | 34 |
| 2023 | 22 |
| 2024 | 28 |
| 2025 | 29 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 240 |
| Terminated | 79 |
| Recruiting | 74 |
| Active, not recruiting | 66 |
| Unknown status | 34 |
| Not yet recruiting | 6 |
| Withdrawn | 5 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 27 |
| AstraZeneca | 25 |
| UNICANCER | 25 |
| Centre Leon Berard | 22 |
| Novartis Pharmaceuticals | 18 |
| Assistance Publique - Hôpitaux de Paris | 14 |
| Pfizer | 14 |
| Gustave Roussy, Cancer Campus, Grand Paris | 12 |
| Institut Bergonié | 12 |
| Institut Curie | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 505 |
| Breast Neoplasms | 95 |
| Neoplasms | 90 |
| Carcinoma, Non-Small-Cell Lung | 67 |
| Colorectal Neoplasms | 64 |
| Lung Neoplasms | 33 |
| Recurrence | 33 |
| Colonic Neoplasms | 26 |
| Melanoma | 26 |
| Prostatic Neoplasms | 25 |
Trials
Showing 76 to 100 of 505. Each trial links to its page on Pharma Observatory.
405 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.